Auricular VNS Following Subarachnoid Hemorrhage
ConditionSubarachnoid Hemorrhage
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAnna Huguenard
About this trial
This study will evaluate whether non-invasive auricular vagal nerve stimulation lowers inflammatory markers, and improves outcomes following spontaneous subarachnoid hemorrhage.
Eligibility criteria
Qualifiers
Spontaneous subarachnoid hemorrhage
Disqualifiers
Trauma-induced subarachnoid hemorrhage
Ongoing chemotherapy
Taking immunosuppressive medications for other medical illnesses
Presence of a pacemaker
Trial design
Treatments tested in this trial
- Auricular Vagus Nerve Stimulation
- Sham Auricular Vagus nerve Stimulation
Treatment groups
50 Participants
are divided into 2 treatment groupsSponsors and collaborators
Anna Huguenard
Lead sponsor
Washington University School of Medicine
Sponsor institution
Source ClinicalTrials.gov